<DOC>
	<DOCNO>NCT00770770</DOCNO>
	<brief_summary>This study ass safety efficacy FA Intravitreal Inserts subject macular edema secondary RVO .</brief_summary>
	<brief_title>Fluocinolone Acetonide Intravitreal Inserts Vein Occlusion Retina</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Fluocinolone Acetonide</mesh_term>
	<criteria>Diagnosis macular edema due branch retinal vein occlusion ( BRVO ) central retinal vein occlusion ( CRVO ) Central subfield thickness &gt; 300 μm BCVA ≥ 24 ≤ 68 letter Males nonpregnant female 18 year Macular edema secondary condition RVO Presence foveal atrophy , dense pigmentary change dense subfoveal exudate study eye Cystic intraretinal hemorrhage involve fovea study eye responsible vision loss Glaucoma ocular hypertension ( IOP &gt; 21 mmHg concurrent therapy screen IOPlowering agent ) Any prior treatment intravitreal , subtenon , periocular steroid antiVEGF therapy since diagnosis RVO study eye Any change systemic steroid therapy within 3 month screen History vitrectomy study eye</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Macular edema secondary RVO</keyword>
</DOC>